Kirk Morris

521 total citations
33 papers, 255 citations indexed

About

Kirk Morris is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kirk Morris has authored 33 papers receiving a total of 255 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 13 papers in Oncology and 7 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kirk Morris's work include Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Kirk Morris is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (7 papers) and Hematopoietic Stem Cell Transplantation (6 papers). Kirk Morris collaborates with scholars based in Australia, United States and United Kingdom. Kirk Morris's co-authors include Glen Kennedy, Peter Mollee, Paula Marlton, Joseph R. Casey, A. J. Beddall, Roger Munro, Saad Al‐Ismail, Devinder Gill, Kathryn Jackson and Jason Butler and has published in prestigious journals such as Blood, British Journal of Haematology and Transfusion.

In The Last Decade

Kirk Morris

30 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kirk Morris Australia 8 84 77 51 44 39 33 255
Khawar Siddiqui Saudi Arabia 12 116 1.4× 74 1.0× 27 0.5× 62 1.4× 42 1.1× 57 358
Francisco Aranha Brazil 11 236 2.8× 92 1.2× 34 0.7× 54 1.2× 43 1.1× 40 389
Juan Garcia Argentina 10 90 1.1× 92 1.2× 32 0.6× 65 1.5× 24 0.6× 33 298
Kazuaki Kameda Japan 11 170 2.0× 63 0.8× 64 1.3× 26 0.6× 20 0.5× 44 308
Richa Chauhan India 9 47 0.6× 61 0.8× 44 0.9× 59 1.3× 41 1.1× 53 293
Elizabeth A. Barker United States 6 172 2.0× 46 0.6× 63 1.2× 35 0.8× 50 1.3× 16 372
CS Rosenfeld United States 10 195 2.3× 93 1.2× 65 1.3× 47 1.1× 39 1.0× 19 475
Tariq Ghafoor Pakistan 12 111 1.3× 60 0.8× 76 1.5× 44 1.0× 119 3.1× 57 350
Agnieszka Zaucha‐Prażmo Poland 10 94 1.1× 68 0.9× 58 1.1× 14 0.3× 65 1.7× 50 253

Countries citing papers authored by Kirk Morris

Since Specialization
Citations

This map shows the geographic impact of Kirk Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Morris more than expected).

Fields of papers citing papers by Kirk Morris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Morris. The network helps show where Kirk Morris may publish in the future.

Co-authorship network of co-authors of Kirk Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Kirk Morris. A scholar is included among the top collaborators of Kirk Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk Morris. Kirk Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shand, Antonia, Joanne Said, Kim Hobbs, et al.. (2025). Haematological malignancies during pregnancy: a systematic review of necessary services in the Australian context. Internal Medicine Journal. 55(3). 393–406.
3.
Kidson‐Gerber, Giselle, Antonia Shand, Antoinette Anazodo, et al.. (2024). Acute Leukaemia in Pregnancy: A Systematic Review of Maternal and Fetal Outcomes. Blood. 144(Supplement 1). 2428–2428.
4.
Martens, Michael J., Michael Straza, Lindsay Puckett, et al.. (2023). Cystic Brain Metastasis Outcomes After Gamma Knife Radiation Therapy. Advances in Radiation Oncology. 9(1). 101304–101304. 1 indexed citations
5.
Tang, Catherine, Verity Chadwick, Kylie D. Mason, et al.. (2022). Capturing the lived experiences of women with lymphoma in pregnancy: a qualitative study. Leukemia & lymphoma. 64(2). 319–328. 6 indexed citations
6.
Campbell, Belinda A., Kylie D. Mason, Matthew Greenwood, et al.. (2021). Lymphoma during Pregnancy: A Multicentre Study By the Australasian Lymphoma Alliance. Blood. 138(Supplement 1). 882–882. 3 indexed citations
7.
Tang, Catherine, Verity Chadwick, Kylie D. Mason, et al.. (2021). Capturing the Lived Experiences of Women with Lymphoma in Pregnancy: An Australasian Lymphoma Alliance Study. Blood. 138(Supplement 1). 4099–4099. 1 indexed citations
8.
Schwarer, Anthony P., Jason Butler, Kathryn Jackson, et al.. (2018). A Comparison of High‐Dose Cytarabine During Induction Versus Consolidation Therapy in Newly Diagnosed AML. HemaSphere. 2(6). e158–e158. 2 indexed citations
11.
Jackson, Kathryn, Peter Mollee, Kirk Morris, et al.. (2013). Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unit. Leukemia & lymphoma. 55(1). 97–104. 25 indexed citations
12.
Casey, Joseph R., et al.. (2013). Oral ribavirin for treatment of respiratory syncitial virus and parainfluenza 3 virus infections post allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplantation. 48(12). 1558–1561. 34 indexed citations
13.
Burge, Matthew, Mohammed F. Islam, Kirk Morris, et al.. (2012). Successful treatment of a primary mediastinal germ cell tumour complicated by hemophagocytic syndrome. Asia-Pacific Journal of Clinical Oncology. 8(4). e97–8. 1 indexed citations
14.
Fairbairn, David J., et al.. (2011). A novel mutation of the erythropoietin receptor gene associated with primary familial and congenital polycythaemia. International Journal of Hematology. 93(4). 542–544. 5 indexed citations
15.
Mollee, Peter, Jill Tate, Kirk Morris, et al.. (2010). Survival and prognostic factors amongst Australian patients with AL amyloidosis. Amyloid. 17. 150–151. 1 indexed citations
17.
Al‐Ismail, Saad, et al.. (2007). Robust, routine haematology reference ranges for healthy adults. International Journal of Laboratory Hematology. 29(4). 279–283. 53 indexed citations
18.
Morris, Kirk, Jill Tate, Devinder Gill, et al.. (2007). Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosis. Internal Medicine Journal. 37(7). 456–463. 20 indexed citations
19.
Robertson, Thomas, et al.. (2004). Diagnosis of granulocytic sarcoma on pleural effusion cytology: Report of a case. Diagnostic Cytopathology. 31(2). 126–128. 8 indexed citations
20.
Morris, Kirk, Bronwyn Williams, & George A. Kennedy. (2004). Heavy bone marrow involvement with metastatic Merkel cell tumour in an immunosuppressed renal transplant recipient. British Journal of Haematology. 128(2). 133–133. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026